{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T01:54:06Z","timestamp":1776909246944,"version":"3.51.2"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:00:00Z","timestamp":1723248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:00:00Z","timestamp":1723248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-024-01487-0","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T12:02:38Z","timestamp":1723291358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["CA-125:CA72-4 ratio \u2212 towards a promising cost-effective tool in ovarian cancer diagnosis and monitoring of post-menopausal women under hormone treatment"],"prefix":"10.1186","volume":"17","author":[{"given":"Angeliki","family":"Margoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios N.","family":"Gargalionis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios G.","family":"Papavassiliou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,10]]},"reference":[{"key":"1487_CR1","doi-asserted-by":"publisher","first-page":"175883592412332","DOI":"10.1177\/17588359241233225","volume":"16","author":"A Ghose","year":"2024","unstructured":"Ghose A, McCann L, Makker S, Mukherjee U, Gullapalli SVN, Erekkath J, et al. Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4. Ther Adv Med Oncol. 2024;16:17588359241233225.","journal-title":"Ther Adv Med Oncol"},{"key":"1487_CR2","unstructured":"Atlanta G. Key statistics for Ovarian Cancer. ACS; 2020."},{"issue":"3","key":"1487_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: Globocan estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1487_CR4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1186\/s12885-018-4898-0","volume":"18","author":"S Sch\u00fcler-Toprak","year":"2018","unstructured":"Sch\u00fcler-Toprak S, Weber F, Skrzypczak M, Ortmann O, Treeck O. Estrogen receptor \u03b2 is associated with expression of cancer associated genes and survival in ovarian cancer. BMC Cancer. 2018;18(1):981.","journal-title":"BMC Cancer"},{"issue":"12","key":"1487_CR5","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1093\/aje\/kwr446","volume":"175","author":"LS M\u00f8rch","year":"2012","unstructured":"M\u00f8rch LS, L\u00f8kkegaard E, Andreasen AH, Kj\u00e6r SK, Lidegaard O. Hormone therapy and different ovarian cancers: a national cohort study. Am J Epidemiol. 2012;175(12):1234\u201342.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1487_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3343\/alm.2020.40.1.40","volume":"40","author":"KH Shin","year":"2020","unstructured":"Shin KH, Kim HH, Kwon BS, Suh DS, Joo JK, Kim KH. Clinical usefulness of cancer antigen (CA) 125, human epididymis 4, and CA72-4 levels and risk of ovarian malignancy algorithm values for diagnosing ovarian tumors in Korean patients with and without endometriosis. Ann Lab Med. 2020;40(1):40\u20137.","journal-title":"Ann Lab Med"},{"issue":"12","key":"1487_CR7","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1158\/1055-9965.EPI-18-0203","volume":"27","author":"BO Akinwunmi","year":"2018","unstructured":"Akinwunmi BO, Babic A, Vitonis AF, Cramer DW, Titus L, Tworoger SS, et al. Chronic medical conditions and CA125 levels among women without ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2018;27(12):1483\u201390.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1487_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cca.2021.11.018","volume":"524","author":"C Zhu","year":"2022","unstructured":"Zhu C, Zhang N, Zhong A, Xiao K, Lu R, Guo L. A combined strategy of TK1, HE4 and CA125 shows better diagnostic performance than risk of ovarian malignancy algorithm (ROMA) in ovarian carcinoma. Clin Chim Acta. 2022;524:43\u201350.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"1487_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5001\/omj.2016.68","volume":"31","author":"K Al Musalhi","year":"2016","unstructured":"Al Musalhi K, Al Kindi M, Al Aisary F, Ramadhan F, Al Rawahi T, Al Hatali K, et al. Evaluation of HE4, CA-125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) in the preoperative assessment of patients with adnexal mass. Oman Med J. 2016;31(5):336\u201344.","journal-title":"Oman Med J"},{"issue":"19","key":"1487_CR10","doi-asserted-by":"publisher","first-page":"14673","DOI":"10.3390\/ijms241914673","volume":"24","author":"MJ Kozie\u0142","year":"2023","unstructured":"Kozie\u0142 MJ, Piastowska-Ciesielska AW, Estrogens. Estrogen Receptors and Tumor Microenvironment in Ovarian Cancer. Int J Mol Sci. 2023;24(19):14673.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1487_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/modpathol.2008.130","volume":"22","author":"RM Issa","year":"2009","unstructured":"Issa RM, Lebeau A, Grob T, Holst F, Moch H, Terracciano L, et al. Estrogen receptor gene amplification occurs rarely in ovarian cancer. Mod Pathol. 2009;22(2):191\u20136.","journal-title":"Mod Pathol"},{"issue":"1","key":"1487_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.30699\/jogcr.9.1.7","volume":"9","author":"F Ameli","year":"2024","unstructured":"Ameli F, Entezarian M, Masir N, Chin TG. Expression of estrogen receptor (ER), progesterone receptor (PR), Her2\/neu in various types of epithelial ovarian tumors. J Obstet Gynecol Cancer Res. 2024;9(1):7\u201313.","journal-title":"J Obstet Gynecol Cancer Res"},{"issue":"9","key":"1487_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.31083\/j.ceog5009199","volume":"50","author":"M Zhang","year":"2023","unstructured":"Zhang M, Xu H, Zhang Y, Li Z, Meng W, Xia J, et al. Research Progress of Estrogen Receptor in Ovarian Cancer. Clin Exp Obstet Gynecol. 2023;50(9):199.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"1","key":"1487_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1757-2215-6-44","volume":"6","author":"E Anastasi","year":"2013","unstructured":"Anastasi E, Granato T, Falzarano R, Storelli P, Ticino A, Frati L, et al. The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer. J Ovarian Res. 2013;6(1):44.","journal-title":"J Ovarian Res"},{"issue":"2","key":"1487_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.47162\/RJME.64.2.05","volume":"64","author":"R Micu","year":"2023","unstructured":"Micu R, Gaia-Oltean AMI, Budi\u015fan L, Braicu C, Irimie A, Berindan-Neagoe I. The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis. Rom J Morphol Embryol. 2023;64(2):159\u201364.","journal-title":"Rom J Morphol Embryol"},{"issue":"1","key":"1487_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13048-019-0591-4","volume":"12","author":"N Sasamoto","year":"2019","unstructured":"Sasamoto N, Babic A, Rosner BA, Fortner RT, Vitonis AF, Yamamoto H, et al. Development and validation of circulating CA125 prediction models in postmenopausal women. J Ovarian Res. 2019;12(1):116.","journal-title":"J Ovarian Res"},{"issue":"5","key":"1487_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1155\/2013\/984641","volume":"35","author":"E Anastasi","year":"2013","unstructured":"Anastasi E, Manganaro L, Granato T, Panici PB, Frati L, Porpora MG. Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer? Dis Markers. 2013;35(5):331\u20135.","journal-title":"Dis Markers"},{"issue":"7","key":"1487_CR18","first-page":"CD011964","volume":"7","author":"C Davenport","year":"2022","unstructured":"Davenport C, Rai N, Sharma P, Deeks JJ, Berhane S, Mallett S, et al. Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women. Cochrane Database Syst Rev. 2022;7(7):CD011964.","journal-title":"Cochrane Database Syst Rev"},{"issue":"15","key":"1487_CR19","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.3390\/cancers14153621","volume":"14","author":"CF Davenport","year":"2022","unstructured":"Davenport CF, Rai N, Sharma P, Deeks J, Berhane S, Mallett S, et al. Diagnostic models combining clinical information, Ultrasound and biochemical markers for ovarian Cancer: Cochrane Systematic Review and Meta-analysis. Cancers (Basel). 2022;14(15):3621.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1487_CR20","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.21037\/gs-20-544","volume":"9","author":"P Giampaolino","year":"2020","unstructured":"Giampaolino P, Foreste V, Della Corte L, Di Filippo C, Iorio G, Bifulco G. Role of biomarkers for early detection of ovarian cancer recurrence. Gland Surg. 2020;9(4):1102\u201311.","journal-title":"Gland Surg"},{"issue":"1","key":"1487_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","volume":"12","author":"V Dochez","year":"2019","unstructured":"Dochez V, Caillon H, Vaucel E, Dimet J, Winer N, Ducarme G. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. J Ovarian Res. 2019;12(1):28.","journal-title":"J Ovarian Res"},{"issue":"20","key":"1487_CR22","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1200\/JCO.2004.03.091","volume":"22","author":"SJ Skates","year":"2004","unstructured":"Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ, et al. Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15\u2009\u2013\u20093, CA 72\u2009\u2013\u20094, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions. J Clin Oncol. 2004;22(20):4059\u201366.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1487_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ygyno.2015.08.024","volume":"139","author":"N Urban","year":"2015","unstructured":"Urban N, Hawley S, Janes H, Karlan BY, Berg CD, Drescher CW, et al. Identifying post-menopausal women at elevated risk for epithelial ovarian cancer. Gynecol Oncol. 2015;139(2):253\u201360.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1487_CR24","first-page":"402","volume":"30","author":"T Nazneen","year":"2021","unstructured":"Nazneen T, Begum SA, Mahmud T, Khatoon F, Islam F, Amatullah M. Preoperative analysis of CA-I25 and its relation with histopathological study in ovarian tumours. Mymensingh Med J. 2021;30(2):402\u20139.","journal-title":"Mymensingh Med J"},{"issue":"1","key":"1487_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3329\/bjmb.v12i1.71596","volume":"12","author":"S Sultana","year":"2019","unstructured":"Sultana S, Hoque M, Sejooti S, Salma U, Akther S, Nipa U. HE4 as a biomarker for diagnosis of malignant ovarian masses in Bangladeshi Population. Bangladesh J Med Biochem. 2019;12(1):11\u20135.","journal-title":"Bangladesh J Med Biochem"},{"issue":"6","key":"1487_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1159\/000534064","volume":"88","author":"H MacHida","year":"2023","unstructured":"MacHida H, Hirakawa T, Tsunekawa K, Kimura T, Murakami M, Abe Y. Revised cut-off value of human epididymis protein 4 enhances its use as an ovarian tumor marker. Gynecol Obstet Invest. 2023;88(6):349\u201358.","journal-title":"Gynecol Obstet Invest"},{"key":"1487_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-023-01936-8","author":"S Kumari","year":"2024","unstructured":"Kumari S, Kumari P, Pankaj S, Rani J, Abhilashi K, Choudhary V, et al. Predictive role of HE4 in diagnosis of ovarian tumors. J Obstet Gynecol India. 2024. https:\/\/doi.org\/10.1007\/s13224-023-01936-8.","journal-title":"J Obstet Gynecol India"},{"issue":"4","key":"1487_CR28","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3390\/cancers15041256","volume":"15","author":"CE Barr","year":"2023","unstructured":"Barr CE, Njoku K, Owens GL, Crosbie EJ. Urine CA125 and HE4 for the detection of Ovarian Cancer in Symptomatic Women. Cancers (Basel). 2023;15(4):1256.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"1487_CR29","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.3390\/cimb45060323","volume":"45","author":"LV Bel\u2019skaya","year":"2023","unstructured":"Bel\u2019skaya LV, Sarf EA, Loginova AI, Vyushkov DM, Choi ED. Potential diagnostic value of salivary tumor markers in breast, lung and ovarian Cancer: a preliminary study. Curr Issues Mol Biol. 2023;45(6):5084\u201398.","journal-title":"Curr Issues Mol Biol"},{"issue":"1\u20132","key":"1487_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.clinbiochem.2014.09.020","volume":"48","author":"AY Gursoy","year":"2015","unstructured":"Gursoy AY, Kiseli M, Ozdemir S, \u015eeker R, Caglar GS. Menstrual cycle variability of CA 72\u2009\u2013\u20094 in healthy women. Clin Biochem. 2015;48(1\u20132):70\u20132.","journal-title":"Clin Biochem"},{"issue":"1","key":"1487_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13048-019-0550-0","volume":"12","author":"B Xin","year":"2019","unstructured":"Xin B, Ji KQ, Liu YS, Zhao XD. Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer. J Ovarian Res. 2019;12(1):75.","journal-title":"J Ovarian Res"},{"issue":"6","key":"1487_CR32","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1177\/00045632211026961","volume":"58","author":"T Duan","year":"2021","unstructured":"Duan T, Chen X, Wu J, Li R, Guo H, Du J, et al. Serum carbohydrate antigen 72\u2009\u2013\u20094 concentrations decrease with age in females but not in males in Beijing, China. Ann Clin Biochem. 2021;58(6):556\u201362.","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"1487_CR33","doi-asserted-by":"publisher","first-page":"FSO145","DOI":"10.4155\/fsoa-2016-0040","volume":"2","author":"P Buderath","year":"2016","unstructured":"Buderath P, Kasimir-Bauer S, Aktas B, Rasch J, Kimmig R, Zeller T, et al. Evaluation of a novel ELISA for the tumor-associated antigen CA 72\u2009\u2013\u20094 in patients with ovarian cancer. Future Sci OA. 2016;2(4):FSO145.","journal-title":"Future Sci OA"},{"key":"1487_CR34","doi-asserted-by":"publisher","first-page":"e00308","DOI":"10.1016\/j.plabm.2023.e00308","volume":"34","author":"F Yanagihara","year":"2023","unstructured":"Yanagihara F, Okura H, Ichikawa H, Shirakawa T, Pan Y, Tu B, et al. Development of an automated chemiluminescent immunoassay for cancer antigen 72\u20134 and the evaluation of its analytical performance. Pract Lab Med. 2023;34:e00308.","journal-title":"Pract Lab Med"},{"issue":"4","key":"1487_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/(SICI)1097-0215(19960822)69:4<329::AID-IJC16>3.0.CO;2-0","volume":"69","author":"U Hasholzner","year":"1996","unstructured":"Hasholzner U, Baumgartner L, Stieber P, Meier W, Reiter W, Fahl H, et al. Clinical significance of the tumour markers CA 125 II and CA 72\u2009\u2013\u20094 in ovarian carcinoma. Int J Cancer. 1996;69(4):329\u201334.","journal-title":"Int J Cancer"},{"issue":"4","key":"1487_CR36","first-page":"1918","volume":"25","author":"M Li","year":"2020","unstructured":"Li M, Men X, Zhang X. Diagnostic value of carbohydrate antigen 72\u2009\u2013\u20094 combined with carbohydrate antigen 15.3 in ovarian cancer, cervical cancer and endometrial cancer. J BUON. 2020;25(4):1918\u201327.","journal-title":"J BUON"},{"issue":"4","key":"1487_CR37","first-page":"931","volume":"31","author":"K Petkova","year":"2019","unstructured":"Petkova K, Chalkov V. The role of tumor markers CA 125, CA 72\u2009\u2013\u20094 and CA 19\u2009\u2013\u20099 in detection and monitoring of the course of disease of ovarian carcinoma and carcinoma of the uterine body. Knowl \u2013 IJ. 2019;31(4):931\u20136.","journal-title":"Knowl \u2013 IJ"},{"issue":"9","key":"1487_CR38","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1007\/s00432-021-03673-9","volume":"147","author":"S Sch\u00fcler-Toprak","year":"2021","unstructured":"Sch\u00fcler-Toprak S, Weber F, Skrzypczak M, Ortmann O, Treeck O. Expression of estrogen-related receptors in ovarian cancer and impact on survival. J Cancer Res Clin Oncol. 2021;147(9):2555\u201367.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1487_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4137\/CMO.S32813","volume":"10","author":"IA Voutsadakis","year":"2016","unstructured":"Voutsadakis IA. Hormone receptors in serous ovarian carcinoma: prognosis, pathogenesis, and treatment considerations. Clin Med Insights Oncol. 2016;10:17\u201325.","journal-title":"Clin Med Insights Oncol"},{"issue":"48","key":"1487_CR40","doi-asserted-by":"publisher","first-page":"84019","DOI":"10.18632\/oncotarget.20251","volume":"8","author":"F Shen","year":"2017","unstructured":"Shen F, Zhang X, Zhang Y, Ding J, Chen Q. Hormone receptors expression in ovarian cancer taking into account menopausal status: a retrospective study in Chinese population. Oncotarget. 2017;8(48):84019\u201327.","journal-title":"Oncotarget"},{"key":"1487_CR41","doi-asserted-by":"publisher","first-page":"827032","DOI":"10.3389\/fendo.2022.827032","volume":"13","author":"XL Xu","year":"2022","unstructured":"Xu XL, Huang ZY, Yu K, Li J, Fu XW, Deng SL. Estrogen Biosynthesis and Signal Transduction in Ovarian Disease. Front Endocrinol. 2022;13:827032.","journal-title":"Front Endocrinol"},{"issue":"10","key":"1487_CR42","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.3390\/cancers15102845","volume":"15","author":"S Sch\u00fcler-Toprak","year":"2023","unstructured":"Sch\u00fcler-Toprak S, Skrzypczak M, Gr\u00fcndker C, Ortmann O, Treeck O. Role of Estrogen Receptor \u03b2, G-Protein coupled estrogen receptor and estrogen-related receptors in endometrial and ovarian Cancer. Cancers (Basel). 2023;15(10):2845.","journal-title":"Cancers (Basel)"},{"issue":"37","key":"1487_CR43","doi-asserted-by":"publisher","first-page":"62400","DOI":"10.18632\/oncotarget.18253","volume":"8","author":"Z Shen","year":"2017","unstructured":"Shen Z, Luo H, Li S, Sheng B, Zhao M, Zhu H, et al. Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis. Oncotarget. 2017;8(37):62400\u201313.","journal-title":"Oncotarget"},{"issue":"1","key":"1487_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41698-022-00288-2","volume":"6","author":"D Cheasley","year":"2022","unstructured":"Cheasley D, Fernandez ML, K\u00f6bel M, Kim H, Dawson A, Hoenisch J, et al. Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression. NPJ Precis Oncol. 2022;6(1):47.","journal-title":"NPJ Precis Oncol"},{"key":"1487_CR45","doi-asserted-by":"publisher","first-page":"166257","DOI":"10.1016\/j.scitotenv.2023.166257","volume":"901","author":"L Chen","year":"2023","unstructured":"Chen L, Lin X, Shi S, Li M, Mortimer M, Fang W, et al. Activation of estrogen-related receptor: an alternative mechanism of hexafluoropropylene oxide homologs estrogenic effects. Sci Total Environ. 2023;901:166257.","journal-title":"Sci Total Environ"},{"issue":"3","key":"1487_CR46","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/ijms18030515","volume":"18","author":"P Rambau","year":"2017","unstructured":"Rambau P, Kelemen LE, Steed H, Quan ML, Ghatage P, K\u00f6bel M. Association of hormone receptor expression with survival in ovarian endometrioid carcinoma: Biological validation and clinical implications. Int J Mol Sci. 2017;18(3):515.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1487_CR47","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1470-2045(13)70253-5","volume":"14","author":"W Sieh","year":"2013","unstructured":"Sieh W, K\u00f6bel M, Longacre TA, Bowtell DD, deFazio A, Goodman MT, et al. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol. 2013;14(9):853\u201362.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1487_CR48","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.tranon.2015.09.002","volume":"8","author":"JM J\u00f6nsson","year":"2015","unstructured":"J\u00f6nsson JM, Arildsen NS, Malander S, M\u00e5sb\u00e4c A, Hartman L, Nilbert M, et al. Sex steroid hormone receptor expression affects ovarian cancer survival. Transl Oncol. 2015;8(5):424\u201333.","journal-title":"Transl Oncol"},{"issue":"11","key":"1487_CR49","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.3390\/ijms22115714","volume":"22","author":"GH Han","year":"2021","unstructured":"Han GH, Hwang I, Cho H, Ylaya K, Choi JA, Kwon H, et al. Clinical significance of tumor infiltrating lymphocytes in association with hormone receptor expression patterns in epithelial ovarian cancer. Int J Mol Sci. 2021;22(11):5714.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1487_CR50","first-page":"277","volume":"48","author":"K Nyangoh-Timoh","year":"2020","unstructured":"Nyangoh-Timoh K, Bendifallah S, Dion L, Ouldamer L, Leveque J. Borderline ovarian tumors: CNGOF guidelines for clinical practice-value of tumor markers. Gynecol Obstet Fertil Senol. 2020;48(3):277\u201386.","journal-title":"Gynecol Obstet Fertil Senol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01487-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01487-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01487-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:02:32Z","timestamp":1723334552000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01487-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1487"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01487-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,10]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"164"}}